Primary dysmenorrhea: new dose of an old medicine offers more options

Reflections
Published
Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine
Primary dysmenorrhea: new dose of an old medicine offers more options
Like

Related Content

Fertility and Sterility
Fertility and Sterility Fertility and Sterility

Primary dysmenorrhea: new dose of an old medicine offers more options

During the past decade, there have been few advances in the treatment of primary dysmenorrhea. Although the basic pathophysiology for primary dysmenorrhea seems well-understood, pharmacologic development appears to have lagged behind. The first tier treatments, nonsteroidal anti-inflammatories and h…

Volume 113, Issue 1, Page 82

Authors:

Amanda C. Yunker, D.O., M.S.C.R.

Abstract:

Reflections on "Evaluation of the efficacy, safety, and clinically recommended dose of dienogest in the treatment of primary dysmenorrhea: a randomized, double-blind, multicenter, placebo-controlled study" by Osuga et al.


Read the full text here.

Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. 

Please sign in or register for FREE

Your Fertility and Sterility Dialog login information is not the same as your ASRM or EES credentials. Users must create a separate account to comment or interact on the Dialog.

Sign In Register

Recommended Content